Release Jan 10 - Barinthus Bio: In a shift to focus on immunology and inflammation indications, the biotech is halting further development of VTP-300 for chronic hepatitis B viral infection and ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Although the U.S. is still the leading country behind biotech innovation, China is close behind, according to a Johnson & Johnson (NYSE:JNJ) business development executive. Nauman Shah, global head of ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology (DBT).

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

Four members of the East Knox FFA competed in the State FFA Agricultural Biotechnology Career Development Event at the Ohio Department of Agriculture on Jan. 24. The local team placed 16th in the ...

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...